Last reviewed · How we verify
amoxicillin or moxifloxacin + rifampicin
amoxicillin or moxifloxacin + rifampicin is a Small molecule drug developed by Centre Hospitalier Universitaire de Nice. It is currently in Phase 3 development.
At a glance
| Generic name | amoxicillin or moxifloxacin + rifampicin |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis (PHASE4)
- Comparing Oral Versus Parenteral Antimicrobial Therapy (PHASE4)
- Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis. (PHASE4)
- Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections (PHASE3)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (EARLY_PHASE1)
- Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- amoxicillin or moxifloxacin + rifampicin CI brief — competitive landscape report
- amoxicillin or moxifloxacin + rifampicin updates RSS · CI watch RSS
- Centre Hospitalier Universitaire de Nice portfolio CI
Frequently asked questions about amoxicillin or moxifloxacin + rifampicin
What is amoxicillin or moxifloxacin + rifampicin?
amoxicillin or moxifloxacin + rifampicin is a Small molecule drug developed by Centre Hospitalier Universitaire de Nice.
Who makes amoxicillin or moxifloxacin + rifampicin?
amoxicillin or moxifloxacin + rifampicin is developed by Centre Hospitalier Universitaire de Nice (see full Centre Hospitalier Universitaire de Nice pipeline at /company/centre-hospitalier-universitaire-de-nice).
What development phase is amoxicillin or moxifloxacin + rifampicin in?
amoxicillin or moxifloxacin + rifampicin is in Phase 3.